Mark Brader
10Patents
4h-index
6Co-inventors
53Inventor score
Filing activity: Oct 22, 1998 → Dec 13, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6268335A | Insoluble insulin compositions | Chemistry; Metallurgy | 68 | Expired |
| US6531448B1 | Insoluble compositions for controlling blood glucose | Human Necessities | 31 | Expired |
| US6465426B2 | Insoluble insulin compositions | Chemistry; Metallurgy | 22 | Expired |
| US11583504B2 | Stabilized formulations of lipid nanoparticles | Chemistry; Metallurgy | 10 | Active |
| US12144895B2 | Stabilized formulations of lipid nanoparticles | Chemistry; Metallurgy | 3 | Active |
| US10588949B2 | Factor IX polypeptide formulations | Chemistry; Metallurgy | 3 | Active |
| US11225650B2 | Methods of using FIX polypeptides | Chemistry; Metallurgy | 3 | Active |
| US11642398B2 | Factor IX polypeptide formulations | Chemistry; Metallurgy | 2 | Active |
| US10391062B2 | Dry transglutaminase composition | Human Necessities | 0 | Active |
| US11193116B2 | Methods of using FIX polypeptides | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.